3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Unknown
2
Recruiting
2
Completed
2
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
3
OTHER
2
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Conditions
Breast Neoplasms
4354
Neoplasms
3056
Prostatic Neoplasms
1904
Colorectal Neoplasms
1739
Lung Neoplasms
1555
Carcinoma, Non-Small-Cell Lung
1270
Pancreatic Neoplasms
981
Leukemia, Myeloid, Acute
952
Multiple Myeloma
951
Lymphoma
912
Head and Neck Neoplasms
894
Leukemia
852
Precursor Cell Lymphoblastic Leukemia-Lymphoma
833
Neoplasm Metastasis
793
Colonic Neoplasms
785
Carcinoma, Hepatocellular
762
Ovarian Neoplasms
757
Melanoma
752
Stomach Neoplasms
742
Rectal Neoplasms
701
Brain Neoplasms
696
Lymphoma, Non-Hodgkin
663
Leukemia, Lymphocytic, Chronic, B-Cell
618
Uterine Cervical Neoplasms
607
Lymphoma, Follicular
559
Glioblastoma
541
Recurrence
539
Hodgkin Disease
532
Esophageal Neoplasms
527
Myelodysplastic Syndromes
508
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
OTHER
×
Arthritis, Juvenile
×
Clear all
NCT01385826
2025-09-08
ADJUVITE
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Completed
34 enrolled
NCT00964210
2011-04-15
HPV
Murdoch Childrens Research Institute
Phase 3
Completed
240 enrolled